Member Info for Manofnomeans

Would have thought shareholders would understand the difference between a medically validated test and a laboratory validated test but I suppose if you are only interested in ramping it's irrelevant.

Tonight's BBC News specifically mentions the Transform project as something that could lead to a reversal of today's decision (which is still predominantly based on the inaccuracy of the conventional PSA test). The Transform trials are funded by Prostate Cancer UK and the UK Government, so today is just one stage of a protracted process. The spokesperson for Prostate Cancer UK that appeared on the news said they are "undeterred" by today's decision.

Prostate cancer UK made it clear, in replies to my previous enquiries, that they are open to including new or emerging tests at anytime during the trials, provided they still have funds available. If OBD proposed trialing PSE and comparing it with the other methodologies already in the Transform project (Stockholm enhanced PSA, saliva test, rapid MRI test), I believe they would be greeted with open arms AND funds to support the necessary tests. A likely outcome would be validation of PSE to the satisfaction of medical regulators making the test an option for the NHS and for a future screening programme in the UK or elsewhere. It is madness that OBD have not acted on this once in a lifetime opportunity.

Yet another incremental increase in Barclsys shareholding today. Tells us all we need to know.

Nice article Swazers but the purchase of a 7.5% share of the Viura field in Spain is set to double or triple PXEN revenues in the very near term. Isn't that a rather glaring omission?

🤣

I have posted a lot on OBD primarily because I was a strong advocate of the science and technology. Then Burrows demonstrated what a blowhard he is and I sold the majority of my holding. I still post here but my focus is now the inept management of the company.

I also enjoy highlighting idiots that pump a company when they selflessly demonstrate an inability to read and understand an RNS. I'll still be posting here for at least 10 weeks and certainly as long as you. I can't resist your offering of cut and paste drivel and tired clichés. 😉

Remember how Burrows promoted this concept as the best route to.market? Seems a bit late to noel acknowledge the need for proper validation and hence inclusion in medical.guidance notes.

As for cutting the burn rate, a recognition of the extravagence of multiple lab facilities is conspicous by its absence. Shareholders to have their holdings severely diluted early next year. Why is our Chairman not demanding a slimmed down passenger list of the OBD gravy train?

Whatever has happened to the 2024 focus on commercialising CiRT and PSE? At best this is an acknowledgement that those efforts are failing and the focus is now back on academic trials to 'stratify' (aka minimise) the market for a specific drug that appears to be effective for the large majority.of patients. No attempt to outline a commercial justification for this effort and no attempt to outline or justify the increased burn rate. Seems to me this will prolong efforts to commercialise existing products and ensures another placing later this year.

It is anything but 'nice'RNS.

@ Mr Hope.

I do believe there are laws prohibiting the kind of insider trading you are suggesting is taking place here.

I'm no fan of the current BoD but even I wouldn't expect them to be that stupid. If they are divulging such information it only harms retail investmors and if I thought it was taking place I'd sell my remaining holding.

@ Aga.

They have been advertising that role intermittently over the last 4 or 5 months. They are committed to funding and opening a UK laboratory to process a coupleof tests per week. It's a total vanity project that flies in the face of their stated intent to focus on the US market. Who knows maybe they filled the post a few months ago and the incumbent just got bored and left.

JV partner Po Valley Energy's S.P. up 7% overnight on ASX.

Still obsessed with me I see. I hope for your sake you were paying attention when, back in Sept/Oct I was suggesting on this thread that folks take a look.at PXEN. If you did then you will have bagged on your investment and more than covered any loss you might have made on SOUC.

The last couple of months production volumes from GH 19-3 take us to a point where the sample size is sufficient to reinforce what were early but premature fears of abnormally high decline rates.

The new wells about to come on stream will need to perform much better or the early promise of this investment will continue to dissipate. Management communications have been appalling which as you seem to have missed it, is something else I was flagging up months ago. Maybe you would benefit from taking a more balanced and mature view of what folks have actually posted? After all PXEN will have been a painful miss if you chose to ignore me based on your opinions of what you think I do or don't know.

Han****, First gas, Tesirollo licence, Director options and El Romerol all in the pipeline of near term news. Give this just a few more weeks and there will be a few regretting selling today. In fact I wouldn't be surprised to see a new ATH by end of this week.

I agree. There's so much news to come in the very short term.

-completion of pre-production seismic survey Selva.
-Signing of off-take agreement(s)
-First Gas Selva
-exercise of BoD options
-formal confirmation of Han**** Mining as new JV partner Iin Spain.
-Update on El Romeral production
-Start of new drilling campaign in Spain-
-Update and likely approval of licence applications (Spain and Italy).
Looks like a truly transformational year ahead!

Good luck with your investment

That's fine. Nobody is stopping you posting, but,
with your permission, I'll feel free to highlight the irrelevance of your posts when they have absolutely no significance to or parallels with events at PXEN. Seems fair, yes?

Peter Wall has absolutely nothing to do with PXEN, so I have no idea why you think someone 'doing a runner' from the Argo Blockchain board merits a post here.

PXEN by contrast was last year's AIM blue riband winner and has just got a huge and very wealthy JV partner for our interests in Spain. Looking cheap at this level.

Having taken over PXEN's Joint Venture partner in Spain and having announced intent to exploit Warrego's Spanish assets, will PXEN become a takeover target?

Interesting times for PXEN shareholders.

https://www.miningweekly.com/article/han****-gains-the-upper-hand-in-warrego-tussle-2023-02-06

Perhaps, but with the FT currently running an article about how Shell's 'big bet on gas is paying off' and PXEN shares quadrupling last year to see them winning the AIM blue riband award, my sense is its about identifying the winners within in-demand sectors.

In the latter case a company sitting on gas assets in mainland Europe has direct access to premium markets and low opex by being land based. There are parallels to SOUC.

Souc is ridiculously oversold in my opinion. With 25% of global gas supplies off-limits to most of the market and with China's manufacturing sector looking to kick on post covid demand will be going up and low NG pricing (its still 2 times higher than recent historical lows) seems unsustainable short of Russia starting to give gas away for free!

I believe the fall in SP here has been driven by retail investors as it has consistently dropped on small volumes. My sense is the SP has reached or is very close to bottoming.

There is money to be made from NG plays that have a competitive advantage and I believe SOUC is one such company. If you need evidence go look at PXEN it's been a multi-bagger for those that got in early. I see them up anther 20-30% in the next month or two with off-take agreements and first gas in Italy ust weeks away. Their finance manager invested 1.5 million two days ago to become a TR1 holder and he isn't on the board.

Educated commitment. The very best variety.

His LinkedIn profile is worth a look!

Bigger trough being ordered at EGM. Based on what one wonders? A resource is worth nothing until.it is out of the ground and that still looks a way off.